de Laet C - Search Results

1

Testing the HTA core model: experiences from two pilot projects.

Pasternack I, Anttila H, Mäkelä M, Ikonen T, Räsänen P, Lampe K, van Brabandt H, Cleemput I, de Laet C, Marchetti M, Refolo P, Sacchini D, Kunz R, Nordmann A, Lühmann D, Freyschuss B; European network for Health Technology Assessment (EUnetHTA). Pasternack I, et al. Among authors: de laet c. Int J Technol Assess Health Care. 2009 Dec;25 Suppl 2:21-7. doi: 10.1017/S026646230999064X. Int J Technol Assess Health Care. 2009. PMID: 20030887

2

Harmonizing HTA.

Pasternack I, Lampe K, de Laet C, Cleemput I, Neyt M, Wild C, Kristensen FB. Pasternack I, et al. Among authors: de laet c. Int J Technol Assess Health Care. 2010 Apr;26(2):226-7. doi: 10.1017/S0266462310000164. Int J Technol Assess Health Care. 2010. PMID: 20392330 No abstract available.

3

Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions.

Cleemput I, Neyt M, Thiry N, De Laet C, Leys M. Cleemput I, et al. Among authors: de laet c. Int J Technol Assess Health Care. 2011 Jan;27(1):71-6. doi: 10.1017/S0266462310001194. Epub 2011 Jan 25. Int J Technol Assess Health Care. 2011. PMID: 21262069 Review.

4

The use of instrumental variables: an alternative to traditional modeling?

Neyt M, Van Brabandt H, De Laet C. Neyt M, et al. Among authors: de laet c. Value Health. 2011 Jan;14(1):1-2. doi: 10.1016/j.jval.2010.11.004. Value Health. 2011. PMID: 21211480 Free article. No abstract available.

5

Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.

Thiry N, De Laet C, Hulstaert F, Neyt M, Huybrechts M, Cleemput I. Thiry N, et al. Among authors: de laet c. Int J Technol Assess Health Care. 2009 Apr;25(2):161-70. doi: 10.1017/S0266462309090217. Int J Technol Assess Health Care. 2009. PMID: 19366497

6

Analysis of the costs of dialysis and the effects of an incentive mechanism for low-cost dialysis modalities.

Cleemput I, De Laet C. Cleemput I, et al. Among authors: de laet c. Health Policy. 2013 May;110(2-3):172-9. doi: 10.1016/j.healthpol.2013.03.001. Epub 2013 Mar 22. Health Policy. 2013. PMID: 23523345

7

Cost-effectiveness analyses of drug eluting stents versus bare metal stents: a systematic review of the literature.

Neyt M, Van Brabandt H, Devriese S, De Laet C. Neyt M, et al. Among authors: de laet c. Health Policy. 2009 Jul;91(2):107-20. doi: 10.1016/j.healthpol.2008.11.014. Epub 2009 Jan 9. Health Policy. 2009. PMID: 19135756 Review.

8

Cost effectiveness of drug-eluting stents in Belgian practice: healthcare payer perspective.

Neyt M, De Laet C, De Ridder A, Van Brabandt H. Neyt M, et al. Among authors: de ridder a, de laet c. Pharmacoeconomics. 2009;27(4):313-27. doi: 10.2165/00019053-200927040-00004. Pharmacoeconomics. 2009. PMID: 19485427

9

Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium.

Neyt M, De Laet C, Van Brabandt H, Franco O, Ramaekers D. Neyt M, et al. Among authors: de laet c. Acta Cardiol. 2009 Feb;64(1):1-10. doi: 10.2143/AC.64.1.2034354. Acta Cardiol. 2009. PMID: 19317290 Review.

10

Calculating an intervention's (cost-)effectiveness for the real-world target population: the potential of combining strengths of both RCTs and observational data.

Neyt M, Cleemput I, Thiry N, De Laet C. Neyt M, et al. Among authors: de laet c. Health Policy. 2012 Jul;106(2):207-10. doi: 10.1016/j.healthpol.2012.04.014. Epub 2012 May 16. Health Policy. 2012. PMID: 22608108

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page